ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 742629 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 742629; 2) Community: the network communities that were significantly associated with the response to NSC 742629; 3) Molecule: the relationships between components within communities and NSC 742629; 4) MDR: the compounds that were significantly associated with the NSC 742629.

NSC Compound Enrichment Correlation
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0164116791870034 0.44968728
NSC 606497 Camptothecin Derivative 0.0164116791870034 0.77378916
NSC 615291 Bizelesin 0.0164116791870034 0.65115834
NSC 672974 Null 0.0164116791870034 0.59997296
NSC 681632 Camptothecin Derivative 0.0164116791870034 0.70248264
NSC 681641 Camptothecin Derivative 0.0164116791870034 0.65383089
NSC 715724 Null 0.0164116791870034 0.1207308
NSC 748512 Null 0.0164116791870036 0.093565089
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.017498903403062 -0.057779487
NSC 163088 Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, chloride (9CI) 0.0174989034030623 0.060254237
Total:76  Current:27    [First] [Prev] [Next] [Last]